Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Krishna Vaddi, PhD$212.5M
Market Cap • 24/04/20242016
(há 8 anos)
2020
(4 years ago)
NASDAQ
Listagem
Wilmington
Sede • Delaware122
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
PRLDSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.